1,338
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

NRSN2 promotes the malignant behavior of HPV-transfected laryngeal carcinoma cells through AMPK/ULK1 pathway mediated autophagy activation

, , , , , , & ORCID Icon show all
Article: 2334463 | Received 20 Dec 2023, Accepted 20 Mar 2024, Published online: 03 Apr 2024

References

  • Antra PP, Hungyo H, Jain A, Ahmad S, Tandon V. Unraveling molecular mechanisms of head and neck cancer. Crit Rev Oncol Hematol. 2022. 178:103778. doi:10.1016/j.critrevonc.2022.103778.
  • Han X, Cheng X, Dai K, Bao W, Ding R, Wan Y. Identification of immunocell infiltrates and effective diagnostic biomarkers in laryngeal carcinoma. Medicine (Baltimore). 2023;102(3):e32548. doi:10.1097/MD.0000000000032548.
  • Ke J, Jia L, Hu Y, Jiang X, Mo H, An X, Yuan W. Clinical and experimental study of a terahertz time-domain system for the determination of the pathological margins of laryngeal carcinoma. World J Surg Oncol. 2022;20(1):339. doi:10.1186/s12957-022-02788-8.
  • Shen N, Duan XH, Wang XL, Yang QY, Feng Y, Zhang JX. Effect of NLK on the proliferation and invasion of laryngeal carcinoma cells by regulating CDCP1. Eur Rev Med Pharmacol Sci. 2019;23(14):6226–9. doi:10.26355/eurrev_201907_18441.
  • Cavaliere M, Bisogno A, Scarpa A, D’Urso A, Marra P, Colacurcio V, De Luca P, Ralli M, Cassandro E, Cassandro C, et al. Biomarkers of laryngeal squamous cell carcinoma: a review. Ann Diagn Pathol. 2021; 54:151787. doi:10.1016/j.anndiagpath.2021.151787.
  • Mannelli G, Lazio MS, Luparello P, Gallo O. Conservative treatment for advanced T3–T4 laryngeal cancer: meta-analysis of key oncological outcomes. Eur Arch Otorhinolaryngol. 2018;275(1):27–38. doi:10.1007/s00405-017-4799-x.
  • Djukic V, Milovanovic J, Jotic AD, Vukasinovic M, Folic MM, Ivanov SY, Satueva DB. Laser transoral microsurgery in treatment of early laryngeal carcinoma. Eur Arch Otorhinolaryngol. 2019;276(6):1747–1755. doi:10.1007/s00405-019-05453-1.
  • Braz DS, Ribas MM, Dedivitis RA, Nishimoto IN, Barros AP. Quality of life and depression in patients undergoing total and partial laryngectomy. Clinics (Sao Paulo). 2005;60(2):135–142. doi:10.1590/S1807-59322005000200010.
  • Li X, Gao L, Li H, Gao J, Yang Y, Zhou F, Gao C, Li M, Jin Q. Human papillomavirus infection and laryngeal cancer risk: a systematic review and meta-analysis. J Infect Dis. 2013;207(3):479–488. doi:10.1093/infdis/jis698.
  • Tsimplaki E, Argyri E, Sakellaridis A, Kyrodimos E, Xesfyngi D, Panotopoulou E. Oropharyngeal and laryngeal but not oral cancers are strongly associated with high-risk human papillomavirus in 172 Greek patients. J Med Virol. 2017;89(1):170–176. doi:10.1002/jmv.24614.
  • Halec G, Holzinger D, Schmitt M, Flechtenmacher C, Dyckhoff G, Lloveras B, Höfler D, Bosch FX, Pawlita M. Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma. Br J Cancer. 2013;109(1):172–183. doi:10.1038/bjc.2013.296.
  • Russell RC, Guan KL. The multifaceted role of autophagy in cancer. EMBO J. 2022;41(13):e110031. doi:10.15252/embj.2021110031.
  • Cassidy LD, Narita M. Autophagy at the intersection of aging, senescence, and cancer. Mol Oncol. 2022;16(18):3259–3275. doi:10.1002/1878-0261.13269.
  • Jain V, Singh MP, Amaravadi RK. Recent advances in targeting autophagy in cancer. Trends Pharmacol Sci. 2023;44(5):290–302. doi:10.1016/j.tips.2023.02.003.
  • Lin C, Blessing AM, Pulliam TL, Shi Y, Wilkenfeld SR, Han JJ, Murray MM, Pham AH, Duong K, Brun SN, et al. Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling. Oncogene. 2021; 40(9):1690–1705. doi:10.1038/s41388-021-01658-z.
  • Garcia-Mayea Y, Mir C, Munoz L, Benavente S, Castellvi J, Temprana J, Maggio V, Lorente J, Paciucci R, LLeonart ME, et al. Autophagy inhibition as a promising therapeutic target for laryngeal cancer. Carcinogenesis. 2019; 40:1525–1534. doi:10.1093/carcin/bgz080.
  • Guo Y, Feng Y, Cui X, Wang Q, Pan X. Autophagy inhibition induces the repolarisation of tumour-associated macrophages and enhances chemosensitivity of laryngeal cancer cells to cisplatin in mice. Cancer Immunol Immunother. 2019;68(12):1909–1920. doi:10.1007/s00262-019-02415-8.
  • Chen XH, Liu J, Zhong JT, Zhou SH, Fan J. Effect of GLUT1 inhibition and autophagy modulation on the growth and migration of laryngeal carcinoma stem cells under hypoxic and low-glucose conditions. Onco Targets Ther. 2021. 14:3069–3081. doi:10.2147/OTT.S300423.
  • Li G, Cheng Z. miR-339-5p inhibits autophagy to reduce the resistance of laryngeal carcinoma on cisplatin via targeting TAK1. Biomed Res Int. 2021. 2021:9938515. doi:10.1155/2021/9938515.
  • Papayannakos CJ, Zhu D, Jung B, Rana AA, DeVoti JA, Abramson AL, et al. Toll-like receptor agonists, poly(I: C) and flagellin, lead to IL-36gamma induction with divergent release kinetics and differentially alter autophagy in primary human keratinocytes. Eur Cytokine Netw. 2022;33:43–53.
  • Tse SW, Tan CF, Park JE, Gnanasekaran J, Gupta N, Low JK, et al. Microenvironmental hypoxia induces dynamic changes in lung cancer synthesis and secretion of extracellular vesicles. Cancers Basel. 2020;12.
  • Tang W, Ren A, Xiao H, Sun H, Li B. Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer. Biomed Pharmacother. 2017. 85:248–255. doi:10.1016/j.biopha.2016.11.012.
  • Keremu A, Maimaiti X, Aimaiti A, Yushan M, Alike Y, Yilihamu Y, Yusufu A. NRSN2 promotes osteosarcoma cell proliferation and growth through PI3K/Akt/MTOR and Wnt/β-catenin signaling. Am J Cancer Res. 2017;7(3):565–573.
  • Yan Z, Xu T, Lu J, Wu Z, Li X, Xu J, Guo W, Dong Z. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway. Pathol Res Pract. 2022. 236:153963. doi:10.1016/j.prp.2022.153963.
  • Jang JE, Eom JI, Jeung HK, Cheong JW, Lee JY, Kim JS, Min YH. Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells. Autophagy. 2017;13(4):761–762. doi:10.1080/15548627.2016.1278328.
  • Ren F, Zhang W, Lu S, Ren H, Guo Y. NRSN2 promotes breast cancer metastasis by activating PI3K/AKT/mTOR and NF-kappaB signaling pathways. Oncol Lett. 2020. 19:813–823. doi:10.3892/ol.2019.11152.
  • Wang G, Yang K. Neurensin‑2 promotes proliferation, invasion and migration of colorectal cancer cells via interaction with SOX12. Oncol Lett. 2020;20(6):1–1. doi:10.3892/ol.2020.12252.
  • Huang HY, Li KN, Lau HC, Hsueh CY, Cong N, Zhang M. Dual inhibition of autophagy and PI3K/mTOR pathway as a potential therapeutic strategy against laryngeal squamous cell carcinoma. Transl Cancer Res TCR. 2022;11(5):1076–1088. doi:10.21037/tcr-21-2325.
  • Chen L, Jia J, Zang Y, Li J, Wan B. MicroRNA-101 regulates autophagy, proliferation and apoptosis via targeting EZH2 in laryngeal squamous cell carcinoma. Neoplasma. 2019;66(4):507–515. doi:10.4149/neo_2018_180811N611.
  • Zhang S, Xie Y, Yan F, Zhang Y, Yang Z, Chen Z, Zhao Y, Huang Z, Cai L, Deng Z, et al. Negative pressure wound therapy improves bone regeneration by promoting osteogenic differentiation via the AMPK-ULK1-autophagy axis. Autophagy. 2022; 18(9):2229–2245. doi:10.1080/15548627.2021.2016231.